Midas International’s Post

The objectives of the STREXIT 2 Project in the words of Dr Winan van Houdt, the Principal Investigator and Co-Leader of the STREXIT 2 Project STREXIT 2 is part of a series of clinical trials funded by the Horizon Europe programme. These trials, led by multistakeholder and multidisciplinary consortiums, form together the European Cancer Cluster. Watch this video, in which Dr Winan van Houdt, STREXIT 2’s Principal Investigator and Co-Leader from the The Netherlands Cancer Institute provides insights into the goals and potential impact of the project. https://lnkd.in/duHNmyFk Find out more about STREXIT 2: https://lnkd.in/eQuVVVyA #STREXIT2_Horizon #HorizonEurope #EUCancerMission #SARCOMA #CancerResearch #ClinicalTrials #Cancer #RetroperitonealSarcoma #SoftTissueSarcoma European Commission EORTC - European Organisation for Research and Treatment of Cancer Sarcoma Patient Advocacy Global Network (SPAGN) Fondazione IRCCS Istituto Nazionale dei Tumori di Milano Syreon Research Institute

In a world of wicked problems, we must straddle disciplines for answers https://lnkd.in/g_Kt_8_x

Some interesting info.

Our latest Annual Report is now available on our website, highlighting progress and patient stories in our relentless pursuit of eliminating prostate cancer. Together, we're combatting stigma, championing early detection, and empowering and supporting patients. As we continue to see a rise in diagnoses in 2024, we will be louder and bolder in our mission to improve outcomes for all people impacted by #prostatecancer. #ZEROProstateCancer #AnnualReport

Through one-on-one interviews, ethnographic research, community mapping, surveys, and more, we spent a year capturing the voices and perspectives of current (and prospective) Kesem community members across the country. We listened, and we heard more about what families facing a parent's cancer really want and need. And we learned. A lot. This extensive discovery effort would go on to inform our next steps as an organization in the years ahead, and shape our plans to enhance current offerings and create new experiences to meet more families where they are and when they need us the most during the cancer journey. 💚 We invite you to transform with Kesem, and read more about our three-year strategic plan to deliver consistent, high-quality programming supporting more of the 5 million children impacted by a parent’s cancer nationwide: https://lnkd.in/gV3jFniA. Kesem’s growth, reach, and ability to provide all programs at no cost to families would not be possible without the generosity of our donors and corporate partners. If you’d like to learn more about our strategy or help us deliver our mission, please contact us at [email protected]. #NonProfit #CancerSupport #CancerResources #StrategicPlanning #StrategicVision #NonProfitLeadership #CorporateSocialResponsibility #CorporatePartnership #NonProfitGrowth #YouthMentalHealth #YouthDevelopment #CommunitySupport

Great way to get important information

Explore the dynamic landscape of Next-Generation Sequencing (NGS) and its transformative potential in genomics. This PDF delves into the latest advancements, emerging trends, and diverse applications of NGS technology, including genome sequencing, transcriptomics, and clinical diagnostics. Uncover how NGS is reshaping personalized medicine, revolutionizing disease research, and propelling genomic innovation. Gain insights into the exciting possibilities that lie ahead in the realm of genomics, as NGS continues to drive breakthroughs in science and healthcare. 🔗 https://bit.ly/46D05PK #Genomics #NGS #FutureTrends #GenomeSequencing #Transcriptomics #ClinicalDiagnostics #PersonalizedMedicine #DNASequencing #NGSTechnology

This is a good case study of how situations can get totally out of control if there’s not enough transparency.